Centivax

Series-A
centivax.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Jul 8, 2025
Investors Undisclosed
Decision Makers 6 Verified

About Centivax

Develops broad-spectrum vaccines, with one in Phase 1 clinical development for influenza.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website centivax.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @centivax (2.8K followers) Created on Apr 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-A announced

    fundraisingfox.com

  2. Milestone

    X account created (@centivax)

    2.8K followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Centivax.

Funding History

1 Round
Series-A · Jul 8, 2025

Founders & Leadership

3

Jacob Glanville

Founder & CEO

Work email & phone locked Unlock →

Nicholas Bayless

CTO

Work email & phone locked Unlock →

Stephanie Wisner

Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts